Lite Strategy (LITS) Assets (2011 - 2026)
Lite Strategy (LITS) posted Assets of $57.8 million for Q1 2026, down 30.32% on a QoQ basis from $82.9 million in Q4 2025, and up 178.11% year-over-year from $20.8 million in Q1 2025.
Analysis
Lite Strategy (LITS) Assets (2011 - 2026) Analysis & Trends
Lite Strategy has reported Assets for 16 years, with the latest figure at $57.8 million in Q1 2026.
- On a quarterly basis, Assets rose 178.11% year-over-year to $57.8 million in Q1 2026; TTM through Mar 2026 was $57.8 million, a 178.11% increase from a year earlier, with the FY2025 full-year figure at $18.3 million, down 55.81% from the prior year.
- Assets was $57.8 million for Q1 2026 at Lite Strategy, down from $82.9 million in the prior quarter.
- The five-year high for Assets was $194.4 million in Q1 2022, with the low at $18.3 million in Q2 2025.
- Average Assets over 5 years is $92.7 million, with a median of $82.9 million recorded in 2025.
- The sharpest annual moves came in 2024 and 2025: Assets plunged 72.59% in 2024, then soared 308.42% in 2025.
- Over 5 years, Assets stood at $147.6 million in 2022, then sank by 46.79% to $78.5 million in 2023, then plunged by 68.95% to $24.4 million in 2024, then soared by 240.11% to $82.9 million in 2025, then sank by 30.32% to $57.8 million in 2026.
- The last three Assets figures came in at $57.8 million (Q1 2026), $82.9 million (Q4 2025), and $113.3 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 95.64 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 49.36 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 27.42 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 41.73 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 10.03 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 10.96 Bn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 5.56 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 32.09 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 5.31 Bn |
| 10 | Lite Strategy | 38.03 Mn | 30.49 Mn | - | 57.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 57.79 Mn |
| Dec 31, 2025 | 82.94 Mn |
| Sep 30, 2025 | 113.34 Mn |
| Jun 30, 2025 | 18.29 Mn |
| Mar 31, 2025 | 20.78 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Sep 30, 2024 | 27.75 Mn |
| Jun 30, 2024 | 41.38 Mn |
| Mar 31, 2024 | 71.26 Mn |
| Dec 31, 2023 | 78.54 Mn |
| Sep 30, 2023 | 101.25 Mn |
| Jun 30, 2023 | 120.81 Mn |
| Mar 31, 2023 | 134.19 Mn |
| Dec 31, 2022 | 147.60 Mn |
| Sep 30, 2022 | 163.58 Mn |
| Jun 30, 2022 | 177.84 Mn |
| Mar 31, 2022 | 194.43 Mn |
| Dec 31, 2021 | 209.46 Mn |
| Sep 30, 2021 | 176.35 Mn |
| Jun 30, 2021 | 174.10 Mn |